Ventyx Biosciences, Inc.
VTYXDelisted Mar 4, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001851194
Ventyx Biosciences, Inc. was delisted on Mar 4, 2026; its insiders filed their last Form 4 on Mar 4, 2026; 139 institutions reported holding it in 13F filings for Q4 2025, worth $471.6M in total; no superinvestor held it.
Q4 2025 vs. Q3 2025
How the institutions holding Ventyx Biosciences, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 110 | 139 | +29 |
| Shares | 43.9M | 52.2M | +8.37M (+19.1%) |
| Value | $136.4M | $471.6M | +$335.2M (+245.8%) |
New holders (51)
Institutions that held Ventyx Biosciences, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (22)
Institutions that held Ventyx Biosciences, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Marshall Wace, LLP | 2,316,275 | $7.20M |
| Vestal Point Capital, LP | 2,050,000 | $6.38M |
| Redmile Group, LLC | 1,073,386 | $3.34M |
| Macquarie Group Ltd | 430,000 | $1.34M |
| Monaco Asset Management SAM | 225,603 | $701.6K |
| StemPoint Capital LP | 167,470 | $520.8K |
| CIBC World Markets Inc. | 155,250 | $482.8K |
| Exome Asset Management LLC | 60,600 | $188.5K |
| Group One Trading, L.P. | 55,569 | $172.8K |
| Simplex Trading, LLC | 49,959 | $155.0K |
| Invesco Ltd. | 49,468 | $153.8K |
| Woodline Partners LP | 45,826 | $142.5K |
| Prelude Capital Management, LLC | 21,200 | $65.9K |
| Susquehanna Fundamental Investments, LLC | 20,777 | $64.6K |
| Jacobs Levy Equity Management, Inc | 19,577 | $60.9K |
| FNY Investment Advisers, LLC | 5,000 | $15.0K |
| Rise Advisors, LLC | 870 | $2.71K |
| Wealthspire Advisors, LLC | 844 | $2.63K |
| Essential Partners LLC | 288 | $896 |
| Farther Finance Advisors, LLC | 100 | $311 |
| Advisor Group Holdings, Inc. | 61 | $190 |
| IFP Advisors, Inc | 5 | $16 |